| Literature DB >> 32636874 |
Elżbieta Król1, Patricia Noguera2, Sophie Shaw3, Eoin Costelloe1, Karina Gajardo4, Victoria Valdenegro4, Ralph Bickerdike5, Alex Douglas1, Samuel A M Martin1.
Abstract
The gill of teleost fish is a multifunctional organ involved in many physiological processes such as gas exchange, osmotic and ionic regulation, acid-base balance and excretion of nitrogenous waste. Due to its extensive interface with the environment, the gill plays a key role as a primary mucosal defense tissue against pathogens, as manifested by the presence of the gill-associated lymphoid tissue (GIALT). In recent years, the prevalence of multifactorial gill pathologies has increased significantly, causing substantial losses in Atlantic salmon aquaculture. The transition from healthy to unhealthy gill phenotypes and the progression of multifactorial gill pathologies, such as proliferative gill disease (PGD), proliferative gill inflammation (PGI) and complex gill disorder (CGD), are commonly characterized by epithelial hyperplasia, lamellar fusion and inflammation. Routine monitoring for PGD relies on visual inspection and non-invasive scoring of the gill tissue (gross morphology), coupled with histopathological examination of gill sections. To explore the underlying molecular events that are associated with the progression of PGD, we sampled Atlantic salmon from three different marine production sites in Scotland and examined the gill tissue at three different levels of organization: gross morphology with the use of PGD scores (macroscopic examination), whole transcriptome (gene expression by RNA-seq) and histopathology (microscopic examination). Our results strongly suggested that the changes in PGD scores of the gill tissue were not associated with the changes in gene expression or histopathology. In contrast, integration of the gill RNA-seq data with the gill histopathology enabled us to identify common gene expression patterns associated with multifactorial gill disease, independently from the origin of samples. We demonstrated that the gene expression patterns associated with multifactorial gill disease were dominated by two processes: a range of immune responses driven by pro-inflammatory cytokines and the events associated with tissue damage and repair, driven by caspases and angiogenin.Entities:
Keywords: RNA-seq; aquaculture; climate change; gene expression; gill inflammation; immune response; proliferative gill disease
Year: 2020 PMID: 32636874 PMCID: PMC7316992 DOI: 10.3389/fgene.2020.00610
Source DB: PubMed Journal: Front Genet ISSN: 1664-8021 Impact factor: 4.599
Sampling details, fish metrics and background.
| Site | Date | SWT (°C)1 | Number of fish | Body mass (kg)2 | Body length (cm)2 | |
| A (Isle of Mull) | 19 Oct 2017 | 13.4 | 31 | 2.4 ± 0.5 | 55 ± 3 | 1.4 ± 0.1 |
| B (Shetland) | 24 Nov 2017 | 13.9 | 20 | 2.4 ± 0.4 | 55 ± 3 | 1.4 ± 0.2 |
| C (Shetland) | 22 March 2018 | 5.7 | 25 | 2.6 ± 0.7 | 55 ± 4 | 1.5 ± 0.2 |
FIGURE 1Approach to representatively divide the gill arch with the highest PGD score between transcriptome profiling and histopathological examination. For transcriptomic profiling, 3 transverse sections from dorsal, medial and ventral regions of the gill were subjected to total RNA extraction to generate individual RNA samples, which were subsequently pooled. All remaining tissue was used for histopathology.
Results of gross gill scoring for proliferative gill disease (PGD), performed on all 8 gill arches of individual fish to identify the gill arch with the highest PGD score for each fish.
| Number of fish grouped by their highest PGD score2 | |||||||
| Site | Median PGD score1 | Score 0 | Score 1 | Score 2 | Score 3 | Score 4 | Score 5 |
| A (Isle of Mull) | 1 (range 1–3.5, n = 31) | - | 10 | 1 | - | ||
| B (Shetland) | 1 (range 1–2, n = 20) | - | 9 | - | - | ||
| C (Shetland) | 1 (range 0–3, n = 25) | - | 10 | 1 | - | ||
Semi-quantitative scoring system used for histopathological examination of gill tissue in sea farmed Atlantic salmon (adapted and modified from Mitchell et al., 2012).
| Parameter | Description |
| LH | Lamellar hyperplasia |
| LF | Lamellar fusion |
| LO | Lamellar oedema |
| CA | Cellular anomalies |
| In | Inflammation (presence of inflammatory cells outside blood vessels) |
| Eg | Eosinophilic granular cells (numbers higher than normal in gill filaments) |
| Cc | Chloride cells (numbers higher than normal and/or abnormal location) |
| Cd | Circulatory disturbances (thrombi, telangiectasis, congestion) |
| Ib | Interlamellar blood (hemorrhage) |
| Ch | Cellular hypertrophy (hydropic degeneration of lamellar cells) |
| bE | |
| bT | |
| Ob | Other bacteria |
| Pp | Protist parasites, |
| Op | Other parasites or agents |
FIGURE 2Individual body mass (A), body length (B) and Fulton’s condition factor K (C) of 43 fish subjected to RNA-seq experiment, plotted by group (PGD 1 and PGD 3) and site (A, B and C). For formula to calculate K, see Table 1.
FIGURE 3Gill transcriptome of 43 fish grouped by PGD score (A) and site (B). Each panel shows a NMDS plot of gene expression profiles between different fish (numbers are fish IDs). The distances on the plots correspond to the leading fold change (FC), which is the average (root-mean-square) Log2 FC for the 500 genes most divergent between each pair of fish. Ellipses indicate 95% confidence intervals, overlapping for fish grouped by PGD score (A) but not for fish grouped by site (B). The stress value of the NMDS ordination is 0.162.
Results of differential gene expression analysis performed on gill transcriptome of 43 fish to elucidate the differences between groups (PGD 3 vs PGD 1) and sites (A vs C, B vs C and A vs B).
| Number of differentially expressed genes (DEGs) | ||||
| Comparison | N1 | Total | Upregulated | Downregulated |
| PGD 3 vs PGD 1 | 17 vs 26 | 0 | 0 | 0 |
| sites A vs C | 20 vs 13 | 1360 | 858 | 502 |
| sites B vs C | 10 vs 13 | 708 | 492 | 216 |
| sites A vs B | 20 vs 10 | 240 | 124 | 116 |
FIGURE 4Gill histopathology of 43 fish grouped by PGD score (A) and site (B). Each panel shows a NMDS plot of histopathological profiles between different fish (numbers are fish IDs). The distances on the plots are calculated from the scores of 12 histopathological parameters (LH, LF, LO, CA, in, eg, cc, cd, ib, ch, pp and op), with 3 parameters (bE, bT and ob) removed from the analysis because all scores were 0 (for parameter abbreviations and details see Table 3 and Supplementary Figure 2). Ellipses indicate 95% confidence intervals, overlapping for fish grouped by PGD score (A) and for fish from sites A and B but not from C (B). Vectors are fitted to visualize the contribution of histopathological parameters to the ordination. The stress value of the NMDS ordination 0.190.
FIGURE 5Approach to identify gene expression patterns associated with multifactorial gill disease. Based on the histopathological examination, A and B were classified as two independent sites with relatively moderate gill histopathology, while C was classified as a site with relatively low gill histopathology. Firstly, the lists of differentially expressed genes (DEGs) for A vs C and B vs C contrasts were generated (FDR < 0.01 and absolute Log2 FC > 1), yielding 1360 and 708 transcripts, respectively. Secondly, both lists of DEGs were checked for common genes (462 in total). Finally, the list of common genes was screened for a commonality of response to ensure that only genes either upregulated or downregulated in both sets of DEGs were considered to constitute a common gene expression profile of non-specific gill inflammation.
Characterisation of 462 potential gene expression markers associated with gill disease.
| Number of genes | ||||
| Gene type | Total | HGNC + | HGNC − | IPA/GO |
| Protein-coding | 354 | 311 | 43 | 311 → 235 |
| Immunoglobulin gene segments | 35 | 0 | 35 | 0 |
| Pseudogenes | 15 | 1 | 14 | 0 |
| Non-coding RNA | 58 | 23 | 35 | 0 |
FIGURE 6Top canonical pathways altered in Atlantic salmon gills with moderate histopathology (sites A and B) vs low histopathology (site C). The analysis was performed on 311 salmon genes mapped to 235 human orthologs, using Ingenuity Pathway Analysis (IPA) and P-value < 0.01. For details and list of corresponding genes see Supplementary Table 8.
FIGURE 7Top upstream regulators predicted from gene expression in Atlantic salmon gills with moderate histopathology (sites A and B) vs low histopathology (site C). The analysis was performed on 311 salmon genes mapped to 235 human orthologs, using Ingenuity Pathway Analysis (IPA). For details and list of corresponding genes see Supplementary Table 9.
FIGURE 8Top downstream effects predicted from gene expression in Atlantic salmon gills with moderate histopathology (sites A and B) vs low histopathology (site C). The analysis was performed on 311 salmon genes mapped to 235 human orthologs, using Ingenuity Pathway Analysis (IPA). For details and list of corresponding genes see Supplementary Table 10.
FIGURE 9Top GO terms (Biological Process) associated with differentially expressed genes (DEGs) in Atlantic salmon gills with moderate histopathology (sites A and B) vs low histopathology (site C). The analysis was performed on 311 salmon genes mapped to 235 human orthologs, using PANTHER overrepresentation test and Bonferroni-corrected P-value < 0.05. The GO terms are sorted by the fold enrichment of the most specific categories, with their parent terms indented directly below. For details and list of corresponding genes see Supplementary Table 11.
Top genes altered in Atlantic salmon gills with moderate histopathology (sites A and B) vs low histopathology (site C), based on FDR < 0.01 and absolute Log2 FC > 2.
| Atlantic salmon genes | Human gene orthologs (HGNC identifiers) | |||||
| Gene ID | Transcript ID | Gene name | Log2 FC1 | Symbol | Name | Log2 FC2 |
| LOC106604507 | XM_014199172.1 | ribonuclease-like 3 | 4.6 | ANG | angiogenin | 4.6 |
| LOC106598253 | XM_014189304.1 | ribonuclease-like 3 | 4.6 | ANG | angiogenin | |
| LOC100196060 | NM_001141089.1 | angiogenin-1 | 4.5 | ANG | angiogenin | |
| LOC100196525 | NM_001141554.1 | chymotrypsin-like | 4.2 | CTRL | chymotrypsin like | 4.2 |
| LOC106577309 | XM_014155258.1 | glutathione peroxidase 6-like | 3.9 | GPX2 | glutathione peroxidase 2 | 3.9 |
| LOC106561635 | XM_014125761.1 | ladderlectin-like | 3.8 | REG1B | regenerating family member 1 beta | 3.8 |
| LOC106577833 | XM_014156195.1 | interleukin-8-like | 3.4 | CXCL9 | C-X-C motif chemokine ligand 9 | 3.4 |
| LOC106601490 | XM_014193713.1 | RING finger protein 208-like | 3.4 | RNF152 | ring finger protein 152 | 3.3 |
| LOC106601491 | XM_014193714.1 | RING finger protein 186-like | 3.2 | RNF152 | ring finger protein 152 | |
| LOC106566533 | XM_014134632.1 | complement C1q tumor necrosis factor-related protein 3-like | 3.2 | C1QTNF3 | C1q and TNF related 3 | 3.1 |
| LOC106566537 | XM_014134640.1 | complement C1q tumor necrosis factor-related protein 3-like | 3.2 | C1QTNF3 | C1q and TNF related 3 | |
| LOC106566534 | XM_014134633.1 | complement C1q tumor necrosis factor-related protein 3-like | 3.0 | C1QTNF3 | C1q and TNF related 3 | |
| LOC106567034 | XM_014135842.1 | complement C1q-like protein 4 | 2.8 | C1QL4 | complement C1q like 4 | 2.8 |
| LOC106573018 | XM_014147615.1 | carboxypeptidase A1-like | 2.9 | CPA1 | carboxypeptidase A1 | 2.7 |
| LOC106598577 | XM_014189609.1 | carboxypeptidase A1-like | 2.8 | CPA1 | carboxypeptidase A1 | |
| LOC100195857 | NM_001140886.1 | carboxypeptidase A1 | 2.6 | CPA1 | carboxypeptidase A1 | |
| LOC106561558 | XM_014125655.1 | carboxypeptidase A1-like | 2.3 | CPA1 | carboxypeptidase A1 | |
| LOC100136358 | XM_014214975.1 | nitric oxide synthase 2 | 2.4 | NOS2 | nitric oxide synthase 2 | 2.4 |
| LOC106594149 | XM_014185514.1 | C-type lectin domain family 4 member E-like | 2.4 | CLEC4E | C-type lectin domain family 4 member E | 2.4 |
| LOC106591222 | XM_014182433.1 | zymogen granule membrane protein 16-like | 2.8 | ZG16 | zymogen granule protein 16 | 2.4 |
| LOC106562680 | XM_014127661.1 | zymogen granule membrane protein 16-like | 2.5 | ZG16 | zymogen granule protein 16 | |
| LOC106562681 | XM_014127663.1 | zymogen granule membrane protein 16-like | 2.4 | ZG16 | zymogen granule protein 16 | |
| LOC106584756 | XM_014170303.1 | zymogen granule membrane protein 16-like | 1.9 | ZG16 | zymogen granule protein 16 | |
| LOC106567571 | XM_014137044.1 | H-2 class II histocompatibility antigen, A-K alpha chain-like | 2.4 | HLA-DPA1 | major histocompatibility complex, class II, DP alpha 1 | 2.4 |
| LOC106585685 | XM_014172160.1 | neurotrophic receptor tyrosine kinase 2 | 2.3 | NTRK2 | neurotrophic receptor tyrosine kinase 2 | 2.3 |
| LOC100286614 | NM_001146553.1 | high choriolytic enzyme 2 | 2.7 | ASTL | astacin like metalloendopeptidase | 2.2 |
| LOC106586984 | XM_014174772.1 | high choriolytic enzyme 1-like | 2.7 | ASTL | astacin like metalloendopeptidase | |
| LOC100195775 | NM_001140804.1 | high choriolytic enzyme 1 | 1.3 | ASTL | astacin like metalloendopeptidase | |
| LOC106591797 | XM_014183059.1 | protein disulfide-isomerase-like | 2.2 | PDIA2 | protein disulfide isomerase family A member 2 | 2.2 |
| LOC106595494 | XM_014186866.1 | protein disulfide-isomerase A2-like | 2.1 | PDIA2 | protein disulfide isomerase family A member 2 | |
| LOC100196492 | NM_001141521.2 | cysteine dioxygenase type 1 | 2.1 | CDO1 | cysteine dioxygenase type 1 | 2.1 |
| LOC100136458 | NM_001123590.1 | tumor necrosis factor alpha-2 precursor | 2.1 | LTA | lymphotoxin alpha | 2.1 |
| LOC106599048 | XM_014190103.1 | retinol-binding protein 1-like | 2.1 | RBP1 | retinol binding protein 1 | 2.1 |
| LOC106573692 | XM_014148970.1 | thyrotropin-releasing hormone receptor-like | 2.1 | TRHR | thyrotropin releasing hormone receptor | 2.1 |
| LOC106589989 | XM_014180468.1 | myosin-7-like | 2.1 | MYH7 | myosin heavy chain 7 | 2.1 |
| LOC106581492 | XM_014163567.1 | P2Y purinoceptor 13-like | 2.1 | P2RY12 | purinergic receptor P2Y12 | 2.1 |
| LOC106581219 | XM_014163130.1 | collagenase 3-like | 2.5 | MMP13 | matrix metallopeptidase 1 | 2.1 |
| LOC106613110 | XM_014215041.1 | collagenase 3-like | 1.7 | MMP13 | matrix metallopeptidase 1 | |
| LOC106581616 | XM_014163747.1 | aconitate decarboxylase 1 | 2.0 | ACOD1 | aconitate decarboxylase 1 | 2.0 |
| LOC106609709 | XM_014208680.1 | complement C1q-like protein 2 | 2.3 | C1QL2 | complement C1q like 2 | 2.0 |
| LOC106596487 | XM_014187765.1 | complement C1q-like protein 2 | 2.3 | C1QL2 | complement C1q like 2 | |
| LOC106592632 | XM_014183971.1 | complement C1q-like protein 2 | 2.3 | C1QL2 | complement C1q like 2 | |
| LOC106601034 | XM_014192902.1 | complement C1q-like protein 2 | 1.1 | C1QL2 | complement C1q like 2 | |
| LOC106609915 | XM_014208958.1 | sialic acid synthase-like | −2.0 | NANS | N-acetylneuraminate synthase | −2.1 |
| LOC106594767 | XM_014186155.1 | sialic acid synthase-like | −2.1 | NANS | N-acetylneuraminate synthase | |
| LOC106609889 | XM_014208923.1 | sialic acid synthase-like | −2.2 | NANS | N-acetylneuraminate synthase | |
| LOC106562772 | XM_014127771.1 | neuronal acetylcholine receptor subunit alpha-7-like | −2.1 | CHRNA7 | cholinergic receptor nicotinic alpha 7 subunit | −2.1 |
| LOC106566856 | XM_014135351.1 | succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial-like | −2.3 | SDHB | succinate dehydrogenase complex iron sulfur subunit B | −2.3 |
| LOC106603364 | XM_014196939.1 | sodium channel subunit beta-4-like | −2.4 | SCN4B | sodium voltage-gated channel beta subunit 4 | −2.4 |
| LOC106594819 | XM_014186204.1 | corticosteroid 11-beta-dehydrogenase isozyme 2-like | −2.4 | HSD11B2 | hydroxysteroid 11-beta dehydrogenase 2 | −2.4 |
| LOC100194860 | NM_001139889.1 | Gamma-aminobutyric acid receptor subunit delta | −2.4 | GABRD | gamma-aminobutyric acid type A receptor delta subunit | −2.4 |
| LOC106607156 | XM_014203794.1 | heat-stable enterotoxin receptor-like | −2.4 | GUCY2C | guanylate cyclase 2C | −2.4 |
| LOC106597204 | XM_014188425.1 | pinopsin-like | −2.5 | OPN3 | opsin 3 | −2.5 |
| LOC106585409 | XM_014171569.1 | spermatid perinuclear RNA-binding protein-like | −2.6 | STRBP | spermatid perinuclear RNA binding protein | −2.6 |
| LOC106596671 | XM_014187940.1 | protein APCDD1-like | −2.9 | APCDD1 | APC down-regulated 1 | −2.9 |
| LOC106586762 | XM_014174368.1 | growth hormone-regulated TBC protein 1-A-like | −2.9 | GRTP1 | growth hormone regulated TBC protein 1 | −2.9 |
| LOC106606833 | XM_014203242.1 | uncharacterized LOC106606833 | −3.1 | MSLNL | mesothelin like | −3.1 |